Effects of Black Tea on Cardiovascular Disease in the Mauritian Population

Status Completed

Clinical Trial Summary

It is proposed to investigate the association between consumption of black tea and various selective fasting blood serum and urine biomarkers in a Mauritian population with ischaemic heart diseases. This study, the first of its kind, will provide clinical data on the potential prophylactic propensities of Mauritian black tea against cardiovascular disease, which remains one of the major health threats to the Mauritian population.

Clinical Trial Description

OBJECTIVES

Our broad objectives will be to:

- Survey and recruit patients with ischaemic heart diseases in a randomized sample representative of the Mauritian population (ethnicity, gender, age, social and economical status) and record their medical history,

- Collect fasting blood serum and urine at baseline and after supplement of control volume of tea infusion and water from study group and control group respectively,

- Optimize techniques to determine levels of specific biomarkers from above body fluid samples,

- Investigate existing correlation between tea consumption and risk of cardiovascular diseases in Mauritian population

Our specific objectives will be to:

- Select a randomised group of the Mauritian population, with ischaemic heart disease, who has been referred to the Cardiac Centre, Pamplemousses for Angiography and a group of people showing no risk of cardiovascular diseases

- Inform the people about the motives of the study and seek consent from those willing to participate in the study,

- Evaluate the levels of biomarkers of oxidative stress (total cholesterol, LDL, HDL, triglycerides, homocysteine, atrial natriuretic peptides, brain natriuretic peptides, 8-hydroxydeoxyguanosine, isoprostanes, hydroxyeicosatetraenoic acid, products of protein damage, uric acid and glycosylated haemoglobin) from 8-10 hr fasting blood serum and urine at baseline from all participants

- Supply the study group with a control volume of tea infusion and the control group with the same amount of water for a defined period of time followed by a two week wash out period with water.

- Study biomarkers as above from 8-10 hr fasting blood serum and urine in two week intervals during the supplement regime

- Investigate the existing correlation between tea consumption and levels of biomarkers of cardiovascular diseases in a Mauritian sample population. ;

Study Design

Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00114907
Study type	Interventional
Source	University of Mauritius
Contact
Status	Completed
Phase	N/A
Start date	June 2005
Completion date	June 2005

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05490303` - HeartGuide: Preliminary Study	N/A
Completed	`NCT05070819` - Atrial Natriuretic Peptide in Assessing Fluid Status	N/A
Not yet recruiting	`NCT04511403` - Prevalence of Oral Mucosal Alterations In a Sample of Egyptian Patients With Cardiovascular Diseases: A Hospital- Based Cross-Sectional Study
Not yet recruiting	`NCT04538469` - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Completed	`NCT02697760` - The CZT Dynamic Myocardial Perfusion Imaging
Terminated	`NCT05157568` - Pilot Randomized Clinical Trial of Live-streamed Cardiovascular Rehabilitation	N/A
Not yet recruiting	`NCT04160845` - Non-invasive Forehead Skin Temperature in Cardiac Surgery
Completed	`NCT04500912` - Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population	N/A
Not yet recruiting	`NCT06438159` - Impact of Mindfulness-Based Stress Reduction Meditation Practice on Patients After Cardiac Rehabilitation.	N/A
Recruiting	`NCT06154473` - Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit
Not yet recruiting	`NCT05877755` - Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging	N/A
Completed	`NCT03394859` - Electronic Medical Records and Genomics (eMERGE) Phase III
Recruiting	`NCT05055830` - Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting	`NCT04374799` - Heparin vs Placebo for Cardiac Catheterization	Phase 3
Completed	`NCT03174106` - Longterm Follow-up of Cardiac Patients With an Smartphone-Application	N/A
Recruiting	`NCT05531253` - Respired Gases in Patients Post Cardiac Surgery
Recruiting	`NCT04609228` - Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors
Recruiting	`NCT06149143` - Cardiac Performance System Data Collection Study - Minnesota
Recruiting	`NCT05725655` - Hot Water Immersion After Myocardial Infarction	N/A
Recruiting	`NCT06073509` - Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.